ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates Post ContentanipRead More You might also be interested in reading Daily Crypto Discussion – May 3, 2026 (GMT+0). August 8, 2025 In Mainstream ← Previous post Next post →